Stem Cells Spin S.A. (WSE:SCS)

Market Cap	15.05M
Revenue (ttm)	115.74K
Net Income (ttm)	-510.92K
Shares Out	41.34M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,512
Average Volume	1,789
Open	0.4280
Previous Close	0.4280
Day's Range	0.3640 - 0.4280
52-Week Range	0.1400 - 0.5150
Beta	0.46
RSI	43.96
Earnings Date	Feb 13, 2026

About Stem Cells Spin

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wroclaw, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O.

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2009
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SCS

Financial Performance

In 2024, Stem Cells Spin's revenue was 54,280, a decrease of -87.06% compared to the previous year's 419,322. Losses were -520,267, 237.1% more than in 2023.